Ticker Scorecard - ME Basics Company: 23andMe Holding Co. IPO Date: November 23, 2020 Sector: Healthcare Industry: Diagnostics and Research Market Cap: $64.92M Activated in VL: True Average Daily Range Avg Daily Range: $0.13 | 3.92% Avg Daily Range (30 D): $0.12 | 3.81% Avg Daily Range (90 D): $0.14 | 4.03% Institutional Daily Volume Avg Daily Volume: .17M Avg Daily Volume (30 D): .2M Avg Daily Volume (90 D): .27M Trade Size Avg Trade Size (Sh.): 14 Avg Trade Size (Sh.) (30 D): 122 Avg Trade Size (Sh.) (90 D): 42 Institutional Trades Total Inst.Trades: 222 Avg Inst. Trade: $2.12M Avg Inst. Trade (30 D): $1.57M Avg Inst. Trade (90 D): $1.57M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.88M Avg Closing Trade (30 D): $11.59M Avg Closing Trade (90 D): $11.59M Avg Closing Volume: 61.96K     News Jan 25, 2025 @ 3:00 PM Deal Dispatch: Lovely Day To Sell Guinness? Plus, ... Source: Anthony Noto Jan 23, 2025 @ 10:42 AM Predictive Genetic Testing and Consumer Genomics M... Source: Researchandmarkets.Com Dec 20, 2024 @ 10:25 PM YourUpdateTV speaks with Marisa Brahney Source: Marisa Brahney Nov 11, 2024 @ 10:30 PM 23andMe Announces Business Restructuring to Stream... Source: N/A Nov 7, 2024 @ 10:54 PM CORRECTION - 23andMe to Report Q2 FY2025 Financial... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS Diluted EPS Revenue $ 193.26M $ 44.07M $ 40.41M Gross Profit $ 89.89M $ 22.41M $ 20.51M Net Income / Loss $ -615.31M $ -59.1M $ -69.4M Operating Income / Loss $ -626.2M $ -61.17M $ -71.96M Cost of Revenue $ 103.37M $ 21.66M $ 19.9M Net Cash Flow $ -127.69M $ -43.37M $ -44.42M PE Ratio     Splits Oct 16, 2024:   20:1